Additionally, high DKC1 expression can promote CRC progression by increasing ribosomal protein expression through Ψ modification and interacting with the HRas proto-oncogene (HRAS) to inhibit the RAS/RAF/MEK/ERK signaling pathway [8, 10]. Here, DKC1 is linked to colorectal carcinoma.